INVS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.899790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.438400E-01
Normal-vs-Stage2
1.293620E-01
Normal-vs-Stage3
4.643500E-02
Normal-vs-Stage4
6.770600E-01
Stage1-vs-Stage2
6.167600E-01
Stage1-vs-Stage3
2.318200E-02
Stage1-vs-Stage4
5.951200E-01
Stage2-vs-Stage3
1.99659955235632E-10
Stage2-vs-Stage4
2.617200E-01
Stage3-vs-Stage4
4.628000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.803040E-01
Normal-vs-AfricanAmerican
4.378800E-01
Normal-vs-Asian
3.891600E-01
Caucasian-vs-AfricanAmerican
5.917400E-01
Caucasian-vs-Asian
4.022600E-01
AfricanAmerican-vs-Asian
9.410200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.608830E-01
Normal-vs-Female
2.440000E-01
Male-vs-Female
5.121000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.667420E-01
Normal-vs-Age(41-60Yrs)
4.999400E-01
Normal-vs-Age(61-80Yrs)
1.168610E-01
Normal-vs-Age(81-100Yrs)
4.546400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.281800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.303000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.532200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.982880E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.899800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.735200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.038250E-01
Normal-vs-Daily Drinker
6.208300E-02
Normal-vs-Weekly Drinker
9.750500E-02
Normal-vs-Occasional Drinker
3.159000E-01
Normal-vs-Social Drinker
5.615200E-01
Non Drinker-vs-Daily Drinker
9.137200E-01
Non Drinker-vs-Weekly Drinker
6.222800E-01
Non Drinker-vs-Occasional Drinker
2.092600E-01
Non Drinker-vs-Social Drinker
1.327440E-01
Daily Drinker-vs-Weekly Drinker
5.302000E-01
Daily Drinker-vs-Occasional Drinker
1.706430E-01
Daily Drinker-vs-Social Drinker
1.171780E-01
Weekly Drinker-vs-Occasional Drinker
4.778000E-01
Weekly Drinker-vs-Social Drinker
3.370800E-01
Occasional Drinker-vs-Social Drinker
6.936200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.688400E-01
Normal-vs-Grade 2
1.890210E-01
Normal-vs-Grade 3
1.646760E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.194200E-01
Grade 1-vs-Grade 3
9.489800E-01
Grade 1-vs-Grade 4
2.688400E-01
Grade 2-vs-Grade 3
5.973000E-01
Grade 2-vs-Grade 4
1.890210E-01
Grade 3-vs-Grade 4
1.646760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.381600E-02
Normal-vs-NonDiabetic
1.999430E-01
Diabetic-vs-NonDiabetic
4.195200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.231000E-01
Normal-vs-NoPancreatitis
1.770560E-01
Pancreatitis-vs-NoPancreatitis
6.982400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.605200E-01
Normal-vs-N1
1.409630E-01
N0-vs-N1
8.714000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.015900E-02
Normal-vs-TP53-NonMutant
3.724200E-01
TP53-Mutant-vs-TP53-NonMutant
1.699990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
